SCHEMBL19795566

SCHEMBL19795566

COc1ccc2c(c1)c1cc(C)ccc1n2-c1ccc(C(F)(F)F)cc1-c1ccc(-c2cc(C(F)(F)F)ccc2-n2c3ccc(C)cc3c3cc(OC)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA1D Q01668 1/20 0.41
▸ PTGDR2 Q9Y5Y4 1/20 0.41
▸ PPARG P37231 1/20 0.41
▸ AKR1C3 P42330 5/20 0.40
▸ AKR1C2 P52895 3/20 0.40
▸ MAOB P27338 1/20 0.39
▸ KIF11 P52732 1/20 0.37
▸ CASR P41180 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ BCHE P06276 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ GRIK1 P39086 1/20 0.35
▸ GRIK2 Q13002 1/20 0.35
▸ HCRTR1 O43613 1/20 0.35
▸ HCRTR2 O43614 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19795550 0.95 CACNA1D (0.44) CACNA1DPTGDR2PPARGAKR1C3AKR1C2
SCHEMBL20364438 0.94 PPARG (0.43) CACNA1DPTGDR2PPARGAKR1C3AKR1C2
SCHEMBL18361012 0.94 CACNA1D (0.45) CACNA1DPTGDR2PPARGAKR1C3AKR1C2
SCHEMBL19795554 0.93 CACNA1D (0.44) CACNA1DPTGDR2PPARGAKR1C3AKR1C2
SCHEMBL17950039 0.93 MAOB (0.44) CACNA1DPTGDR2PPARGAKR1C3AKR1C2
SCHEMBL19795570 0.91 CACNA1D (0.41) CACNA1DPTGDR2PPARGAKR1C3AKR1C2
SCHEMBL18361106 0.89 CACNA1D (0.48) CACNA1DPTGDR2PPARGAKR1C3AKR1C2
SCHEMBL20276946 0.88 AKR1C3 (0.43) CACNA1DPTGDR2PPARGAKR1C3AKR1C2
SCHEMBL18361117 0.88 PPARG (0.46) CACNA1DPTGDR2PPARGAKR1C3AKR1C2
SCHEMBL20364435 0.88 CACNA1D (0.44) CACNA1DPPARGAKR1C3AKR1C2KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180026202-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026202-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES ORC3, OR10J3, C1R CACNA1D 1372/4885PTGDR2 2025/4885PPARG 4624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback